Latest news
EXEL: Q2 2026 revenues rose 10% year-over-year, with Zanza's CRC NDA under review and guidance trimmed - tradingview.comtradingview.com · Wed, 05 Aug 2026 23:25:49 GMTEXEL: Q2 2026 revenues rose 10% year-over-year, with pivotal trials advancing for future growth - tradingview.comtradingview.com · Wed, 05 Aug 2026 22:48:17 GMT